Latest filing published 07 Oct 2021 for IDEAYA Biosciences, Inc., €14k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Michael P. Dillon on record concern IDEAYA Biosciences, Inc., in the capacity of senior executive. The record holds 9 filings, for trades running from 11 May 2021 to 4 October 2021.
On the market, this insider has only sold: 1 sale, €211k in total. Other entries cover 8 option exercises.
The record was last updated on 7 October 2021 with an option exercise (€14k) in IDEAYA Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations